The winners of the fifth annual Prix Galien USA represent the progress of the entire industry and show us how far we’ve come in advancing the pace of innovation and commercializing new medicines that save lives and improve standard of care.
Pharmaceutical Executive served as a lead media partner for the 2011 Prix Galien awards, held September 27 at the Museum of Natural History in New York City. The annual gala awards dinner, which recognizes innovation in products and agents that improve the human condition, brings together stakeholders and top influencers in the industry, including professional and scientific groups, academia, patient associations, and more for a night of celebration.
This year, top winners were Janssen’s Stelara and Amgen’s Prolia and XGEVA for Best Biotechnology Product; and Pfizer’s Prevnar 13 for best medical agent. Additionally, Dr. Paul Farmer—medical anthropologist, physician, Kolokotrones University Professor at Harvard University, Chair of the Department of Global Health and Social Medicine at Harvard Medical School, and founding director of international non-profit organization Partners in Health—took home the Pro Bono Humanum award.
“Dr. Farmer is an exemplary model of how one person can be a catalyst between science, business, and government to serve as a beacon of hope to those in need. Dr. Farmer’s dedication to combating deadly diseases while fighting poverty and inequality in developing countries is inspirational,” said Nobel Peace Prize winner and Prix Galien USA 2011 Award selection committee member Professor Elie Wiesel in a statement.
As another year of innovation in the industry comes to a close and is honored by Prix Galien, Gerry Weissmann, chairman of the committee of the Prix Galien, reflects on all that’s been accomplished: “After two centuries of tough, sometimes controversial experimentation, we’ve replaced pre-FDA home remedies and snake oil with drugs that address the basic mechanisms of human disease,” he said during the ceremony. “This year, the score of candidates for the Prix Galien USA shows what happens when we bring basic science from the bench to the bedside in a bottle or pill that’s been approved by the FDA … Teddy Roosevelt would have been proud that the industry he helped save from snake oil has made a difference in human life.”